HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatsuya Ohno Selected Research

Heavy Ion Radiotherapy

8/2022Long-term survivor of hepatocellular carcinoma treated with repeated carbon ion radiotherapy and transarterial chemoembolization: a case report.
8/2022A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution.
5/2022Pembrolizumab After Carbon Ion Radiation Therapy for Alveolar Soft Part Sarcoma Shows a Remarkable Abscopal Effect: A Case Report.
4/2022Long-term survival of two patients with inoperable post-irradiation osteosarcoma treated with carbon-ion radiotherapy: a case report.
3/2022Carbon-ion Radiotherapy for Inoperable Head and Neck Bone and Soft-tissue Sarcoma: Prospective Observational Study.
2/2022Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer.
1/2022Relationship between oral mucositis and the oral bacterial count in patients with head and neck cancer undergoing carbon ion radiotherapy: A prospective study.
1/2022Dosimetric analysis of intraocular hemorrhage in nonsquamous head and neck cancers treated with carbon-ion radiotherapy.
1/2022Efficacy and Safety of 4 Fractions of Carbon-Ion Radiation Therapy for Hepatocellular Carcinoma: A Prospective Study.
1/2022Normal Tissue Complication Probability Model for Acute Radiation Dermatitis in Patients With Head and Neck Cancer Treated With Carbon Ion Radiation Therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatsuya Ohno Research Topics

Disease

116Neoplasms (Cancer)
10/2022 - 03/2004
88Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 12/2005
27Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2022 - 06/2003
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 09/2014
18Prostatic Neoplasms (Prostate Cancer)
07/2022 - 12/2004
17Hepatocellular Carcinoma (Hepatoma)
08/2022 - 12/2004
17Carcinoma (Carcinomatosis)
05/2022 - 06/2003
12Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 03/2015
12Lung Neoplasms (Lung Cancer)
12/2021 - 01/2012
11Adenocarcinoma
01/2022 - 09/2004
10Melanoma (Melanoma, Malignant)
10/2022 - 12/2004
9Sarcoma (Soft Tissue Sarcoma)
08/2022 - 12/2004
9Neoplasm Metastasis (Metastasis)
01/2022 - 06/2003
7Rectal Neoplasms (Rectal Cancer)
11/2021 - 12/2004
5Osteosarcoma (Osteogenic Sarcoma)
04/2022 - 01/2020
4Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 01/2015
4Lymphatic Metastasis
01/2020 - 05/2007
4Mucositis
12/2019 - 01/2015
4Adenoid Cystic Carcinoma (Cylindroma)
10/2018 - 12/2004
3Squamous Cell Carcinoma of Head and Neck
01/2022 - 10/2017
3Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 01/2011
3Dermatitis
01/2022 - 07/2017
3Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 01/2014
3Chordoma
05/2021 - 12/2004
3Esophageal Neoplasms (Esophageal Cancer)
04/2021 - 05/2007
3Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2021 - 05/2013
3Stress Fractures (Stress Fracture)
01/2021 - 01/2010
3Leukopenia
12/2019 - 10/2006
3Hyperthermia
01/2018 - 08/2010
3Hypoxia (Hypoxemia)
01/2011 - 04/2006
3Chronic Disease (Chronic Diseases)
01/2006 - 03/2004
2Breast Neoplasms (Breast Cancer)
05/2022 - 10/2021
2Alveolar Soft Part Sarcoma
05/2022 - 11/2013
2Adenocarcinoma of Lung
01/2022 - 07/2014
2Hemorrhage
01/2022 - 09/2018
2Stomatitis
01/2022 - 10/2016
2Liver Neoplasms (Liver Cancer)
11/2021 - 01/2017
2Disease Progression
08/2021 - 08/2018
2Interstitial Lung Diseases (Interstitial Lung Disease)
08/2021 - 08/2015
2Radiation Pneumonitis
04/2021 - 06/2017
2Adenosquamous Carcinoma
11/2020 - 11/2010
2Merkel Cell Carcinoma
01/2020 - 08/2019
2Cholangiocarcinoma
01/2019 - 06/2016
2Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
10/2018 - 01/2018
2Necrosis
10/2017 - 01/2006
2Brain Neoplasms (Brain Tumor)
09/2015 - 01/2013
2Second Primary Neoplasms (Neoplasms, Second)
11/2007 - 01/2006
1Lymphadenopathy
03/2022
1Acquired Immunodeficiency Syndrome (AIDS)
02/2022
1Colonic Neoplasms (Colon Cancer)
01/2022

Drug/Important Bio-Agent (IBA)

44CarbonIBA
10/2022 - 01/2006
17Cisplatin (Platino)FDA LinkGeneric
04/2021 - 10/2006
12Biological ProductsIBA
07/2022 - 12/2004
8IonsIBA
10/2022 - 01/2007
6DNA (Deoxyribonucleic Acid)IBA
07/2022 - 06/2007
4Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2021
4Proteins (Proteins, Gene)FDA Link
12/2021 - 09/2004
4squamous cell carcinoma-related antigenIBA
08/2021 - 06/2003
3AndrogensIBA
07/2022 - 02/2015
3Immune Checkpoint InhibitorsIBA
05/2022 - 04/2021
3Protons (Proton)IBA
12/2021 - 01/2017
3B7-H1 AntigenIBA
12/2021 - 06/2021
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
05/2022 - 10/2021
2MetalsIBA
01/2022 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2021 - 11/2010
2Dihydrotachysterol (AT 10)IBA
09/2018 - 04/2018
2Paclitaxel (Taxol)FDA LinkGeneric
02/2016 - 03/2015
2Radiation-Sensitizing AgentsIBA
11/2015 - 03/2015
2Indicators and Reagents (Reagents)IBA
11/2010 - 12/2006
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2010 - 11/2007
24-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
08/2006 - 03/2004
1Glucose (Dextrose)FDA LinkGeneric
08/2022
1RNA (Ribonucleic Acid)IBA
07/2022
1SiliconesIBA
05/2022
1SolutionsIBA
05/2022
1AntigensIBA
05/2022
1pembrolizumabIBA
05/2022
1durvalumabIBA
03/2022
1Messenger RNA (mRNA)IBA
01/2022
1Immune Checkpoint ProteinsIBA
12/2021
1gadolinium ethoxybenzyl DTPAFDA Link
11/2021
1palbociclibIBA
10/2021
1DenosumabFDA Link
10/2021

Therapy/Procedure

137Heavy Ion Radiotherapy
08/2022 - 12/2004
121Radiotherapy
10/2022 - 06/2003
43Therapeutics
07/2022 - 03/2004
38Brachytherapy
05/2022 - 01/2005
20Chemoradiotherapy
05/2022 - 11/2007
10Drug Therapy (Chemotherapy)
10/2022 - 01/2010
7Aftercare (After-Treatment)
07/2022 - 12/2015
6Re-Irradiation
10/2022 - 04/2013
5Conservative Treatment
12/2019 - 06/2017
3Immunotherapy
01/2022 - 04/2021
3Palliative Care (Palliative Therapy)
12/2021 - 08/2019
3Drug Tapering
01/2020 - 01/2010
3Patient Positioning
10/2018 - 01/2017
3Conformal Radiotherapy
07/2017 - 08/2010
2X-Ray Therapy
07/2022 - 10/2011
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020 - 01/2017
1Castration
07/2022